多种捐赠者的密集便微生物移植用于活性性结肠炎:随机对照试验
Sudarshan Paramsothy1, Michael A Kamm2, Nadeem O Kaakoush3
1St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia; Department of Gastroenterology, St Vincent's Hospital, Sydney, NSW, Australia; Department of Gastroenterology, Nambour General Hospital, Nambour, QLD, Australia; Department of Gastroenterology, Bankstown-Lidcombe Hospital, Sydney, NSW, Australia.
与安慰剂相比,强化便微生物移植 (FMT) 显著改善了活性性结肠炎的缓解率. 这种新疗法对性结肠炎具有前景, 微生物变化与结果有关.
科学领域:
- 胃肠病学
- 微生物学
- 免疫学
背景情况:
- 性结肠炎的发病与肠道微生物群有关.
- 便微生物移植 (FMT) 是一种新的治疗方法,在性结肠炎中有效性不确定.
研究的目的:
- 在活跃的性结肠炎中确定强度剂量,多捐赠者的FMT的疗效.
主要方法:
- 一个多中心,双盲,随机,安慰剂对照试验.
- 患者接受了FMT或安慰剂输液和阴道,持续了8周.
- 主要结局:在第8周没有使用类固醇的临床和内学缓解.
主要成果:
- 在FMT组的27%和安慰剂组的8%实现了缓解 (p=0. 021).
- 微生物多样性在FMT后增加,与结果相关的特定类型.
- 各组的不良反应相似;没有显著的安全问题.
结论:
- 强度剂量,多捐赠者的FMT有效地诱导了性结肠炎的缓解和内改善.
- FMT是一种有前途的治疗选择, 微生物变化与临床结果相关.
- 未来的研究应该优化治疗强度和捐赠者与接受者的匹配.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents


